Le Lézard
Classified in: Health, Science and technology
Subject: OFR

DSM - delivery of shares


This is a press release by Koninklijke DSM N.V. (Royal DSM), pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the Decree) in connection with the public offer by Danube AG (to be renamed DSM-Firmenich AG) for all the issued and outstanding ordinary shares in the capital of DSM (the Exchange Offer). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. This press release is not for general release, publication or distribution, in whole or in part, in or into, directly or indirectly, the United States or any other jurisdiction where such release, publication or distribution would violate applicable laws or regulations.

HEERLEN, Netherlands, Jan. 17, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

DSM Logo

Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 17 January 2023, delivered 50 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (average exercise price ?112.00). On the date hereof, the total number of issued and outstanding DSM ordinary shares is 173,081,040. As a consequence of the delivery included herein, the number of outstanding DSM ordinary shares increased by 0.0000%.

DSM
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders ? customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on:
LinkedIn: http://www.linkedin.com/company/3108   
Twitter: http://www.twitter.com/DSM  
Facebook: http://www.facebook.com/DSMcompany 
YouTube: http://www.youtube.com/user/dsmcompany

For more information

DSM Media Relations

Gareth Mead

tel. +31 (0) 45 5782420

email [email protected]

DSM Investor Relations

Dave Huizing

tel. +31 (0) 45 5782864

email [email protected]

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg 


These press releases may also interest you

at 16:35
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that registration is open for the two-day virtual public meeting, "FDA's Fifth Online Controlled Substances...

at 16:25
The Memorial Health System (MHS) partnered with InVita Healthcare Technologies (InVita), Oracle Health, and Mississippi Organ Recovery Agency (MORA), the federally designated Organ Procurement Organization (OPO) serving most of the state of...

at 16:15
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...

at 16:12
As a bill holding oil drillers accountable for health harms awaits a vote on the California Assembly Floor, Chevron reported spending $3 million lobbying in the first three months of the year to defeat that bill, AB 3155, the only bill it claims to...

at 16:10
Great Place to Work Institute and its senior care partner, Activated Insights, have once again honored Clearwater Living with certification as a Great Place to Work. This accolade marks the fifth time the company has participated in the survey and...

at 16:10
Envista Holdings Corporation ("Envista") today announced that the company will participate in the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 4:10 ? 4:40 pm ET in a Fireside Chat. There will be an audio-only recording link that can...



News published on and distributed by: